Synthetic peptide blocks key asthma inflammation switch in cells and mice

A team from the University of Bonn and the Research Center Borstel, Leibniz Lung Center (FZB) has discovered a previously unknown mechanism of action for a synthetic peptide that mitigates excessive inflammatory responses in allergic asthma.

This mechanism specifically inhibits a key inflammatory switch in the immune system and opens new avenues for treating chronic inflammatory diseases.

The findings have been published in the journal Advanced Science. ...